Top compounds associated with response to SPRY4


Feature Type Standardized
Nominal ANOVA
mRNA AZD6244 CCLE pan-cancer AAC 0.28 4e-08
mRNA FH535 GDSC1000 pan-cancer AAC 0.21 4e-08
mRNA SB590885 GDSC1000 pan-cancer AAC 0.19 7e-08
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA AS605240 GDSC1000 pan-cancer AAC 0.19 2e-07
mRNA PLX4720 CCLE pan-cancer AAC 0.25 6e-07
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA RAF265 CTRPv2 pan-cancer AAC 0.21 3e-06
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA PLX4720 GDSC1000 pan-cancer AAC 0.15 6e-06
Download CSV